NEW YORK, NY / ACCESSWIRE / May 28, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against HF Foods Group Inc. ("HF Foods" or "the Company") (NASDAQ:HFFG) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired HF Foods securities between August 23, 2018 and March 23, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/hffg.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) HF Foods engaged in undisclosed related party transactions; (2) HF Foods insiders and related parties were enriching themselves by misusing shareholder funds; (3) HF Foods was "gaming" the FTSE/Russell Index by masking the true number of shares free floating; and (4) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/hffg or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in HF Foods you have until May 28, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 591155

NEW YORK, NY / ACCESSWIRE / May 28, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against VMware, Inc. ("VMware " or "the Company") (NYSE:VMW) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired VMware securities between March 30, 2019 and February 27, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/vmw.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements that: (1) VMware's reporting with respect to its backlog of unfilled orders was not in compliance with all relevant accounting and disclosure requirements; (2) the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny and/or investigation; and (3) as a result, the Company's public statements were materially false and misleading at all relevant times.

On February 27, 2019, VMware disclosed a U.S. Securities and Exchange Commission ("SEC") investigation into its backlog of unfilled orders. Specifically, VMware advised investors that the SEC requested a series of documents and information related to the Company's backlog and associated accounting and disclosures in December 2019. On this news, VMware's stock price fell $15.11 per share, or 11.14%, to close at $120.52 per share on February 28, 2020.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/vmw or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in VMware you have until June 1, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 591160

Business Model Designed to Withstand Economic Downturns

MIAMI, FL / ACCESSWIRE / May 28, 2020 / Novus Acquisition and Development, Corp. (OTC PINK:NDEV), through its wholly-owned subsidiary WCIG Insurance Services, Inc., is an insurance entity in health and, the nation's first carrier offering cannabis health plans to recreation and medicinal users, today reported, its financial and operational results for the three months ended March 31, 2020.

"The year 2020 shows continual increases in the number of lives covered that continues to drive our revenue growth," stated, Frank Labrozzi, CEO of Novus. "Our Cannabis MedPlan and its business model is designed to weather economic adversity, even during this global COVID-19 pandemic."

First Quarter 2020 Financial Highlights:

Revenue increased $7,403 or 14% to $59,077 for the three months ended March 31, 2020, as compared to the three months ended March 31, 2019
Demonstrated a 34% profit margin pricing structure in its business model for the three months ended March 31, 2020
Net income increased $2,828 or 16% to $20,308 for the three months ended March 31, 2020, as compared to the three months ended March 31, 2019
No dilution to the total shares outstanding this reporting period, with no insider sales
Shareholder equity remained strong with an increase to $1,445,891 at March 31, 2020, from $1,426,431 at December 31, 2019
Cash and Cash Equivalents increased to $152,968 at March 31, 2020, from $149,822 at December 31, 2019
Increased Zip Code Availability In Our Network Provider Coverage Area
Executed Contract With Mark Kuban To Head Broker Relations
Continued to Ramp with Managing General Agency (MGA) with Healthfield Solutions, LLC

Increased Agent/Affiliate Base:

Our Agent/Affiliate base grew 10% with 840 active reps. Our growth potential is tied to these participants book of business throughout the year as opposed to the two months during Open Enrollment.

Increased Network Provider Coverage Area

Expansion in our network of THC providers servicing our patient/members in areas that offer delivery options citywide and statewide covering over 22,000 zip codes. CBD providers offer nationwide delivery for CBD with participating top brands. We invite you to review our latest coverage of providers.

Click on the Map to View Provider Network

Executed Contract With Mark Kuban To Head Broker Relations

Mark Kuban is a 30-year powerhouse veteran with Colonial Life & Accident, Sun Life, and National InsureTech platforms for the communication of benefits. One of the country's leading producer, resulting in the largest first-year increase in production by field sales in National & Regional Association/Group through a national broker distribution network.

He is experienced in implementing techniques in marketing, training producers in cross selling that has successfully expanded into 27 states. He provides a supporting role to agent/affiliates with InsureTech enrollment technologies, carrier selection, and revenue increase by building participation within their current book of business.

Continues to Ramp Up With Managing General Agency (MGA), Healthfield Solutions, LLC

Novus executed an MGA Agreement with insurance entity Healthfield Solutions, LLC, to market the Novus Cannabis MedPlan. Healthfield Solutions will educate its arsenal of 1,600 agents, that will sell and bundle Novus Cannabis MedPlan with their own dental, life, and supplemental health plans and sell it to their client base of over 250,000.

Continues to Ramp Up With Ease.com, a Second FinTech Insurance Platform

Ease.com is a benefits administration and HR FinTech platform for businesses with 2-250 employees, accessed by 1,200 insurance brokers. Ease.com digitally mapped Novus' benefit plans for easy quotation submissions that is accessed by 60,000 consumer visitors per month.

Additionally, employees who are enrolled by their employer can view via a dashboard a side-by-side plan comparisons with coverage details and the cost per-pay-period giving the employees the opportunity discuss benefit options with their dependents. Then confidentially modify important benefit details like plan summaries and policy variances to determine eligibility at their discretion.

Financial Results for the Three Months Ended March 31, 2020

Revenue increased by $7,403 or 14.3% to $59,077 for the three months ended March 31, 2020, as compared $51,674 for the three months ended March 31, 2019. The growth was primarily due to expansion into new territories, market awareness / visibility of the Novus Cannabis MedPlan offering and an increased number of strategic partners, dispensary providers and lives covered. The Healthcare Reimbursement Act and the acceptance of credit cards for policy payments has increased usage.

Income from operations increased by $2,828 or 16.2% to $20,308 for the three months ended March 31, 2020, as compared $17,480 for the three months ended March 31, 2019. The increase in income from operations was primarily due to an increase in revenue and a decrease in professional fees.

The Company's Balance Sheet remained strong with an increase in the cash balance to $152,968 and Shareholder Equity to $1,4445,891.

Financial Filings: Click Here
Quote: Click Here
Website: Click Here
Investor's Page: Click Here
How Insurance Companies are Valued: Click Here
Media Coverage: Click Here

Resources:

Source: "Total expenditures in millions by source of payment and insurance coverage, United States, 2017," Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey, 2017, https://meps.ahrq.gov/mepstrends/hc_use/.

About Novus

Novus Acquisition & Development Corp. (NDEV), through its subsidiary WCIG Insurance, provides health insurance and related insurance solutions within the wellness and medical marijuana industries in states where legal programs exist. Novus has developed its infrastructure within many lines of the insurance business such as health, property & casualty, life, accident, and fixed annuities.

Novus' medical cannabis benefits package will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on these press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. Once a push notification is competed the transaction is solely between the state-licensed dispensary and the registered patient.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state-designated laws, allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government's enforcement of current federal laws could cause significant financial changes to Novus Medical Group. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

Forward-Looking Statements

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contact Information

855-228-7355
Email: info@getnovusnow.com

SOURCE: Novus Acquisition and Development, Corp.

ReleaseID: 591813

SHENZHEN, CHINA / ACCESSWIRE / May 28, 2020 / Huawei announced the worldwide launch of the next-generation mass storage system – OceanStor Pacific Series. The series delivers efficient, cost-effective, and reliable services for AI, HPC, videos, and other mass data scenarios by breaking architectural, service, and performance boundaries, and leveraging uncompromised multi-protocol interworking, next-generation elastic EC algorithm, and a series of dedicated hardware. This series marks a new standard for future-oriented mass data storage, helping enterprises fully unleash data power in the intelligent age.

The fourth industrial revolution has made digital production the currency of modern business models. Digital production turns data into opportunities, then these opportunities into services, and finally into profits. With this new production factor, enterprises must find a way of cost-effectively collecting and storing different types of data such as structured data from core services and mass unstructured data from 5G, IoT, and UHD. Enterprises use AI technologies to analyze and process the massive amounts of data to convert data into knowledge and services, improving production efficiency.

Peter Zhou, President of Huawei Data Storage and Intelligent Vision Product Line, said, "Mass data will play an increasingly important role in enterprise digital transformation. Today, only 2% of global data is stored, and only 10% of the data is being mined for further value. Enterprises are facing insufficient capacity, data silos, and complex management when dealing with mass data. Our OceanStor Pacific Series is designed to answer these pain points, setting a new benchmark for efficient, economical, everlasting mass data storage, and helping us become the trusted choice for mass data."

Peter Zhou, President of Huawei Data Storage and Intelligent Vision Product Line, releasing the next-generation OceanStor Pacific Series

Shang Haifeng, President of Huawei Mass Storage Domain, elaborated on Huawei's three strategic directions for mass data scenarios:

Leading technologies: Huawei builds a series of dedicated hardware and leverages software innovations such as multi-protocol interworking, efficient reduction algorithms, and multi-level reliability to meet scenario-specific needs.
Business innovations: Huawei leverages industry-leading data redundancy protection and reduction technologies to be the first industry player to promote the business model for available capacity. This model enables users to know exactly what they are getting from the start, helping lower procurement costs, TCO, and the usage threshold of mass storage.
Industry expertise: Driven by industry-specific requirements, Huawei constantly innovates its products, accelerates the digital transformation of enterprises, and unleashes data power.

Efficient, Economical, and Everlasting: The Trusted Choice for Mass Data

Huawei released its first generation of file storage in 2009 and has continuously invested in mass data storage ever since, ranking No. 1 in market share in China for four consecutive years. The OceanStor Pacific Series aims to become the trusted choice for mass data by fully utilizing years of know-how in software and hardware, and making groundbreaking innovations in efficiency, cost, and reliability.

Efficient: This series breaks the service boundary to implement uncompromised interworking of file, HDFS, and object protocols, addressing performance and semantic loss issues caused by traditional gateways. In autonomous driving R&D, one Huawei storage system streamlines data processing across different phases. Data does not need to be migrated between multiple storage systems, improving service processing efficiency by 25% and reducing space by 20%. By breaking the performance boundary, the next-generation file system supports bandwidth- and OPS-intensive applications, adapting to increasingly complex HPC loads.
Economical: This series breaks the architectural boundary with the innovative, high-reliability vNode mode along with the next-generation elastic EC technology. It yields a disk utilization of up to 93%, over 40% higher than the industry average, without compromising performance and reliability. Its brand-new node with high density and large capacity supports 120 disks in just a 5 U space with 2.67x density than general-purpose storage servers and 62.5% space reduction. Hot, warm, and cold data is automatically tiered onto SSDs, HDDs, and Blu-ray disks on demand, meaning that data can flow freely without intervention.
Everlasting: The series provides a four-level mechanism for data, devices, systems, and solutions to ensure high reliability. Its comprehensive sub-health detection and pre-processing identify fault risks before they occur. The OceanStor Pacific Series uses cross-cluster active-active and three-site multi-active DR mechanisms for cross-region DR, ensuring 24/7 online services of banking images, online videos, and other production applications.

Huawei OceanStor storage has been deployed in more than 150 countries for more than 12,000 customers in a variety of sectors, including carriers, finance, government, energy, healthcare, manufacturing, and transportation. Huawei OceanStor storage is the ideal choice for worldwide customers looking to store and process their service data.

About Huawei

Huawei is a leading global provider of information and communications technology (ICT) infrastructure and smart devices. With integrated solutions across four key domains – telecom networks, IT, smart devices, and cloud services – we are committed to bringing digital to every person, home and organization for a fully connected, intelligent world.

Huawei's end-to-end portfolio of products, solutions and services are both competitive and secure. Through open collaboration with ecosystem partners, we create lasting value for our customers, working to empower people, enrich home life, and inspire innovation in organizations of all shapes and sizes.

At Huawei, innovation focuses on customer needs. We invest heavily in basic research, concentrating on technological breakthroughs that drive the world forward. We have more than 194,000 employees, and we operate in more than 170 countries and regions. Founded in 1987, Huawei is a private company fully owned by its employees.

For more information, please visit Huawei online at www.huawei.com or follow us on:

http://www.linkedin.com/company/Huawei
http://www.twitter.com/Huawei
http://www.facebook.com/Huawei
http://www.youtube.com/Huawei

Contact:

Raymond Chou
raymond.chou@wmglobal.com

SOURCE: Huawei

ReleaseID: 591620

SALT LAKE CITY, UT / ACCESSWIRE / May 28, 2020 / IONIQ Sciences Inc. ("IONIQ Sciences" or the "Company"), announced it is initiating an institutional private equity offering on the heels of receiving ‘Breakthrough Device Designation' from the U.S. FDA for its lung cancer test. IONIQ Sciences has also re-branded from ProLung, Inc. to IONIQ Sciences, Inc. (dba) to reflect its mission to dramatically improve the cancer landscape with a modern solution for the early detection of cancer thereby expanding the therapeutic window, significantly improving survivability, and reducing the cost of healthcare. Proceeds from the offering are intended to fund the company's expansion into developing additional single cancer tests and a multi-cancer screen.

The securities to be offered in the institutional offering will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold absent registration or an exemption from registration under the Securities Act.

Nothing in this press release constitutes an offer to buy, or a solicitation of an offer to sell, securities in the United States or any other jurisdiction in which such offer or solicitation would be unlawful. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act.

About IONIQ Sciences, Inc.

IONIQ Sciences, Inc. is developing advanced multi-cancer screening technology for early detection that will expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. IONIQ Sciences operates at the confluence of its Electrical Impedance Analytics (EIA) technology and artificial intelligence (AI). IONIQ Science's first product utilizing its proprietary analytic platform, the ProLung Test™ for lung cancer, has been designated a Breakthrough Device by the U.S. FDA. ProLung rebranded to IONIQ Sciences in May 2020.

Forward-Looking Statements
Statements contained in this release that are not purely historical, including, without limitation statements regarding IONIQ Sciences' future performance and goals, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties such as those described in the IONIQ Sciences' Annual Report on Form 10-K for the year ended December 31, 2017 and subsequent filings with the Securities and Exchange Commission. Such risks and uncertainties include inherent risks and uncertainties relating to IONIQ Sciences' ability to meet its funding requirements for its operations and other commitments and to obtain successful test results and regulatory approvals for its products. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections.

For further information about IONIQ Sciences Inc., please contact:

Andy Robertson | 1-801-503-9231| acr@IONIQsciences.com
IONIQ Sciences, Inc., Vice President of Business Development
IONIQ Sciences, Inc.
350 W. 800 N., Suite 214
Salt Lake City, Utah 84103
USA
www.IONIQsciences.com

Follow IONIQ Sciences, Inc. on Twitter, Facebook and LinkedIn: @IONIQSciences

SOURCE: ProLung, Inc.

ReleaseID: 591661

SUGAR LAND, TX / ACCESSWIRE / May 28, 2020 / Neutra Corp. (OTC PINK:NTRR) has completed payments on the last of its convertible debts with one of its lenders, demonstrating the company's strength and preparing it for future growth opportunities. The retiring of this debt places Neutra in a better position to thrive as the world begins reopening amidst the ongoing COVID-19 pandemic.

"The retiring of this convertible debt testifies to the soundness of our business plan," said Neutra CEO Sydney Jim. "Even in a time of growing economic uncertainty, we were able to meet our goals and retire debt. Now we are focusing on our operation, growth and expansion into new markets without hindrance. The market for hemp-based CBD products has never been greater, and thanks to our new facility in Houston and our Texas hemp license, we ready for bigger and brighter days ahead."

Neutra last month announced it was ready to open a hemp processing and CBD manufacturing site in Houston. This came shortly on the heels of the news Neutra subsidiary VIVIS had been granted a hemp-handling license in the state of Texas. The license enables VIVIS to legally cultivate and process hemp in the Lone Star State. The last two moves were key parts in the company's long-term vertical integration strategy, which means Neutra now controls its hemp supply from cultivation, to processing to manufacturing to sales.

About Neutra Corp.

Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at https://neutrainc.com.

NOTICE REGARDING FORWARD LOOKING STATEMENT

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.

Neutra Contact:

Sydney Jim
888-433-4033
info@neutrainc.com

SOURCE: Neutra Corp

ReleaseID: 591812

Emily Stroud shares that now is not the time to be afraid; instead it's an opportunistic time to create financial freedom in your life

FORT WORTH, TX / ACCESSWIRE / May 28, 2020 / Right now in the financial markets, there is a lot of uncertainty surrounding what's to come in the future… Expert Financial Advisor, Emily Stroud, shares a simple and powerful message on how to navigate the uncharted waters currently being faced.

Financial stress is cited as one of the most common reasons for divorce, mental health issues, and substance abuse. It can be paralyzing for anyone when they realize they are unable to meet their needs and without the right help, you may feel like there is no hope. Fortunately, Emily Stroud has made it her life's passion to help people with their financial goals, and find freedom through faith-based, practical financial planning methods.

Her book, Faithful Finance: 10 Secrets to Move from Fearful Insecurity to Confident Control, outlines simple steps you can take to create the type of future you desire. Her belief is that true wealth comes from God, and he has instructed us to honor him by being wise with our spending. This means giving generously, saving thoughtfully, and using it to better the lives of your loved ones.

She is also currently in production to launch a TV show centered around her book Faithful Finance. Her dream is to empower people from all walks of life by instructing them on savings techniques, growing wealth, and giving back. The show is going to be produced and distributed on a national streaming network and Emily is using this incredible opportunity to show the importance of financial planning to the masses.

Emily is a credentialed Chartered Financial Analyst, the most prestigious designation in investment management, with over 20 years of experience, and is fully licensed with the SEC.

This accomplishment is not only a testament to her intelligence, it is also an example of how hard she is willing to work. Out of 1.4 million that test for their CFA, less than 15% actually pass, and 19% of those that pass are women. She received her MBA in finance from Texas Christain University and owns her own boutique investment firm, Stroud Financial Management, in Fort Worth, Texas. Her goal is to guide you towards a life free from fears associated with money, and make your dollars work for you.

Through passive income strategies, Emily will help you prepare for retirement and realize that it is not the end of your life, it is the beginning of a new chapter filled with freedom to do what you really love. Whether it is traveling, finding your forever home, supporting grandkids through college, or just living confidently with peace of mind, Emily is the faith-based, financial guru you need to plan your dream future.

If you are struggling with financial planning, Emily is giving away a FREE digital workbook titled, "10 Days to Financial Freedom" that also includes a free budget worksheet on her website: www.emilygstroud.com. You can access it by entering your email address on her website where prompted.

"By trade, I'm a financial advisor and author. By God's grace, I'm a wife and mother to two amazing kids. Faithful Finance is a book about ten secrets to living your best financial life possible."

– Emily G. Stroud, Faithful Finance

Disclosure Information: Emily G. Stroud is a Chartered Financial Analyst. Securities are offered through Cambridge Investment Research, Inc.,a Broker/Dealer, Member FINRA/SIPC. Investment Advisor Representative, Cambridge Investment Research Advisors, Inc., a Registered Investment Advisor. Cambridge and Stroud Financial Management, Inc. are not affiliated.

CONTACT:

Contact Name: Emily Stroud
Business Name: Stroud Financial Management
Address: Fort Worth, Texas
Phone Number: (866) 484-7019
Website Link: www.emilygstroud.com

SOURCE: Emily Stroud

ReleaseID: 591453

Shrimp market players are focusing on collaborations with local distributors to address challenges of trade restrictions to sustain growth through the end of the COVID-19 pandemic.

DUBAI, UAE / ACCESSWIRE / May 28, 2020 / Restrictive measures set up by governments in order to flatten the coronavirus curve continue to challenge the growth of several verticals in food sector. Limitations on imports, exports, and even local transport of goods is heavily impacting the prospects of fresh products such as shrimp. In addition to seafood markets sinking amid the pandemic and export restrictions resulting in stockpiling of seafood, global shrimp market is bearing the brunt of temporary closure of foodservice sector. A recent Future Market Insights (FMI) study forecasts the market to reach a US$ 4.9 Bn valuation between 2019 and 2029, and suggests that the fall of market amid outbreak will create opportunities for canned shrimp and related products in near term.

"Shrimp has been an affordable seafood. Prior to the pandemic, the demand for shrimp was strongly on the rise owing to its availability and nutritional properties. Moreover, the cost of producing shrimp products is reducing owing to advances in manufacturing technologies. The market is likely to recovery at a rapid clip once the outbreak subsides," says the FMI analyst.

Request report sample with 200+ pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-1838

Key Takeaways of Shrimp Market Study

While food applications of shrimp products will continue as the primary source of revenue, cosmetic and personal care applications are now displaying notable growth.
Farmed white leg shrimp will remain highly sought-after, substantially surpassing tiger shrimp varieties.
Frozen shrimp products hold major revenue share, while canned variants display high CAGR.
Conventional cultivation methods for shrimp farms remain dominant, while organic alternatives are projected to gain ground during the forecast period.
Asia will hold a major share of the global shrimp market, with North America and Europe playing catch up with increasing health consciousness among consumers.

Shrimp Market – Key Growth Factors

The rising popularity of healthy lifestyles and diets, and the resultant consumer bias towards protein-based products, over calorie-based products is driving market growth.
The growing demand for seafood products in food service businesses, supported by the relatively lower prices of shrimp drive market growth through the forecast period.
Growing niche of cosmetic and pharmaceutical applications of shrimp in anti-aging products contributes to the market.
Advances in infrastructure, R&D, and funding for production processes will support the market growth through 2029.

Shrimp Market – Key Restraints

Overfishing practices have decimated wild shrimp stocks which, result in price fluctuations hindering market growth.
Health and environment concerns associated with conventional shrimp farms are also having a negative impact on the market.

Impact of COVID-19 on Shrimp Market

The global seafood is facing a growing threat of seafood products piling up, driven by the restrictions imposed on exported goods during the covid-19 pandemic. Shrimp has become a flourishing sector. However, oversupply and declining prices have been key challenges.

Shrimp shipments have also slumped sharply as supply chains remain disrupted, particularly in major consumer nations such as China. In addition, lockdown and stay-at-home orders continue to generate a fall in food service businesses, reducing demand. Post congestion and mobility restrictions will harshly impact the market, compounded by the concerns over food safety in wet markets.

Explore the full shrimp market report with 110 illustrative figures, 96 data tables and table of contents. Request ToC of the study at

https://www.futuremarketinsights.com/askus/rep-gb-1838

Competitive Landscape of Shrimp Market

Some of the major companies profiled in this FMI report include, but are not limited to, Natural Shrimp Inc., Clover Leaf Seafoods Family, Royal Greenland S/A, Charoen Pokphand Food plc, Pescanova S.A., Maruha Nichiro Corp., High Liner Food Industry Inc., Nippon Suisan Kaisha Ltd., Baton Rouge Shrimp Co., Marine Harvest ASA, Gulf Shrimp Co., and Thai Union Frozen Products plc. The key players in shrimp market are seeking mergers and acquisitions to bolster market presence. Shrimp product manufacturers are also focusing on mergers and acquisitions to bolster product portfolio.

More About the Report

This FMI study of 250 pages provides all-inclusive insights on the global shrimp market. The market analysis is based on nature (organic and conventional), species (gulf shrimps, farmed white leg shrimps, banded coral shrimps, royal red shrimps, giant tiger shrimps, blue shrimps, and ocean shrimps), form (canned, breaded, peeled, cooked & peeled, shell on, and frozen) sales channel (direct sales and indirect sales) and application (food industry, pharmaceutical industry, cosmetics industry, industrial, and biotechnology), across seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa).

Explore Extensive Coverage of FMI's Food & Beverages Landscape

Plant-based Snacks Market– Get the latest insights on the global plant based snacks market through FMI's study covering detailed qualitative and quantitative analysis for predefined projection period (2019-2028).

Clean Label Ingredients Market– FMI's detailed study on the global clean label ingredients market encompasses emerging trends, technological advancements, key players, and prominent strategies for the course of forecast period (2019-2029).

Tempeh Market– Obtain comprehensive analysis on the global tempeh market through FMI's latest report covering key regions, competitive analysis along with segmental analysis for 2019-2026.

About FMI

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FMI helps clients from across the globe with their unique business intelligence requirements. With a repository of over thousand reports and 1 million+ data points, the team has scrutinized the food & beverages sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/shrimp-market
Press Release Source: https://www.futuremarketinsights.com/press-release/shrimp-market

SOURCE: Future Market Insights

ReleaseID: 591804

The pandemic has created multiple challenges facing producers of proanthocyanidins; disturbed transport, logistics, and supply chain account for a considerable wastage.

DUBAI, UAE / ACCESSWIRE / May 28, 2020 / Consumer inclination towards preventive healthcare and rising preference for functional dietary supplements continue to drive the revenue pool of proanthocyanidins market. One of the abundantly available natural phytochemicals, proanthocyanidins continue to gain traction on the back of their multiple health benefits, particularly in enhancing metabolism and improving hair and skincare.

A new Future Market Insights (FMI) study has projected a healthy 6.4% CAGR for the market over 2020 – 2030. However, COVID-19 pandemic has brought along some serious challenges to market growth through 2020. While consumers are refraining from purchasing non-essential products amid the pandemic, it is directly posing a harsh impact on sales of proanthocyanidins-based nutritional supplements. Manufacturing, logistics, and supply chain obstacles are primarily hindering the growth of proanthocyanidins market amid pandemic.

"The spread of COVID-19 is likely to have a notable impact on demand. The anti-cancer properties of these flavonoids will however play an important role in the recovery of market soon after the pandemic subsides, and production facilities get back to normal," says the FMI analyst.

Request report sample with 200+ pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-11423

Key Takeaways of Proanthocyanidins Market Report

Type A proanthocyanidins will continue to hold the lead during the pandemic, and a strong growth rate through the forecast period.
With the high demand from functional food and beverage applications, proanthocyanidins are also playing key roles in dietary supplements.
Grape seed based proanthocyanidins are hold a primary market position while cranberry variants are playing catch up.
North America holds a major share of the global proanthocyanidins market, with most demand arising from the United States in food and pharma applications.

Proanthocyanidins Market – Key Growth Factors

Rising consumer bias for natural ingredients and functional foods and beverages is one of the primary factors sustaining adoption of proanthocyanidins.
Extensive demand for proanthocyanidins in skin and hair care applications, particularly aimed towards anti-aging formulations support the market.
The prevalent trend preventive healthcare management in pharmaceutical applications is pushing the adoption of proanthocyanidins.
Frequent developments in dietary supplement formulations, particularly in developing countries will support the market growth.

Proanthocyanidins Market – Key Restraints

Side effects associated with proanthocyanidins such as indigestion, dry mouth and sore throat are impacting adoption, hindering market growth.
Low consumer awareness about proanthocyanidins and their health benefits is also a factor hampering growth in the industry.

Impact of COVID-19 on Proanthocyanidins Market

The global proanthocyanidins market is expected to greatly impacted by the coronavirus pandemic. Transport, trade, and production restrictions, imposed by governments has resulted in major changes in consumer patterns, which generate short term sales opportunities, to leverage panic buying behaviors. On the other hand, consumers are less likely to make visits to stores, affecting proanthocyanidins consumption. Further, disruptions to supply chains and transport is expected to result in greater levels of losses and wastage till the end of the pandemic.

Explore the full proanthocyanidins market report with 112 illustrative figures, 128 data tables and table of contents. Request ToC of the study at https://www.futuremarketinsights.com/askus/rep-gb-11423

Competitive Landscape of Proanthocyanidins Market

Some of the major companies profiled in this FMI report include, but are not limited to, Skin Actives Scientific, NOW Health Group Inc., Bio Botanica Inc., Atrium Innovations Inc., Ocean Spray Cranberries Inc., Swanson Health Products Inc., and IL Health & Beauty Natural Oils Co. Inc. Players in proanthocyanidins market are largely focused on product development for multiple applications, investments in research to back nutrition claims, which will remain key in boosting demand for proanthocyanidins in the near future.

More About the Report

This FMI study of 250 pages provides all-inclusive insights on the global Proanthocyanidins market. The market analysis is based on application (food & beverages, dietary supplements, and personal care & cosmetics), source (pine bark, grape seed, and berries), and distribution channel (drug and pharmacy store, convenience stores, modern trade, and online retail), across six regions (North America, Latin America, Europe, Asia, Oceania, Middle East & Africa).

Explore Extensive Coverage of FMI's Food & Beverages Landscape

Dehydrated Vegetables Market– Get the latest insights on the global dehydrated vegetables market through FMI's study covering detailed qualitative and quantitative analysis for predefined projection period (2018-2028).

Sweetener Market– FMI's detailed study on the global sweetener market encompasses emerging trends, technological advancements, key players, and prominent strategies for the course of forecast period (2017-2027).

Corn Wet Milling Market– Obtain comprehensive analysis on the global corn wet milling market through FMI's latest report covering key regions, competitive analysis along with segmental analysis for 2019-2029.

About FMI

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FMI helps clients from across the globe with their unique business intelligence requirements. With a repository of over thousand reports and 1 million+ data points, the team has scrutinized the food & beverages sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact:

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/proanthocyanidins-market
Press Release Source: https://www.futuremarketinsights.com/press-release/proanthocyanidins-market

SOURCE: Future Market Insights

ReleaseID: 591803

NEW YORK, NY / ACCESSWIRE / May 28, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Liberty Oilfield Services, Inc. (NYSE:LBRT)

CONTACT JAKUBOWITZ ABOUT LBRT:
https://claimyourloss.com/securities/liberty-oilfield-services-inc-loss-submission-form/?id=6965&from=1

The LBRT Lawsuit is on behalf of investors who purchased securities pursuant and/or traceable to the documents issued in connection with the Company's January 2018 initial public offering.

Lead Plaintiff Deadline : June 2, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) there was an oversupply in the hydraulic fracturing services market; (2) the Company's pricing power was weak; (3) Liberty's services were not increasing and its competition was not decreasing; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

GSX Techedu Inc. (NYSE:GSX)

CONTACT JAKUBOWITZ ABOUT GSX:
https://claimyourloss.com/securities/gsx-techedu-inc-loss-submission-form/?id=6965&from=1

Class Period : June 6, 2019 – April 13, 2020

Lead Plaintiff Deadline : June 16, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) GSX overstated its profitability, revenue, student enrollment figures, teacher qualifications, and teacher selection process; (ii) the foregoing, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Hallmark Financial Services, Inc. (NASDAQ:HALL)

CONTACT JAKUBOWITZ ABOUT HALL:
https://claimyourloss.com/securities/hallmark-financial-services-inc-loss-submission-form/?id=6965&from=1

Class Period : March 5, 2019 – March 17, 2020

Lead Plaintiff Deadline : July 6, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked effective internal controls over accounting and financial reporting related to reserves for unpaid losses; (2) the Company improperly accounted for reserve for unpaid losses and loss adjustment expenses related to its Binding Primary Commercial Auto business; (3) as a result, Hallmark Financial would be forced to report a $63.8 million loss development for prior underwriting years; (4) as a result, Hallmark Financial would exit from its Binding Primary Commercial Auto business; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law

ReleaseID: 591806